0001189727-18-000012.txt : 20180621
0001189727-18-000012.hdr.sgml : 20180621
20180621182542
ACCESSION NUMBER: 0001189727-18-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180621
FILED AS OF DATE: 20180621
DATE AS OF CHANGE: 20180621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BURCAR ALISON D
CENTRAL INDEX KEY: 0001189727
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 18912770
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL INC
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER NAME:
FORMER CONFORMED NAME: BRUMMETT BURCAR ALISON
DATE OF NAME CHANGE: 20020916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-06-21
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001189727
BURCAR ALISON D
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Vice President and Gen'l Mgr.
Common Stock
2018-06-21
4
X
0
13219
88.76
A
13219
D
Common Stock
2018-06-21
4
X
0
1976
58.79
A
15195
D
Common Stock
2018-06-21
4
S
0
3320
295.27
D
11875
D
Common Stock
2018-06-21
4
S
0
4704
296.34
D
7171
D
Common Stock
2018-06-21
4
S
0
5502
297.38
D
1669
D
Common Stock
2018-06-21
4
S
0
1412
298.24
D
257
D
Common Stock
2018-06-21
4
S
0
257
301.12
D
0
D
Non-Qualified Stock Option (right to buy)
58.79
2018-06-21
4
X
0
1976
0.0
D
2024-02-24
Common Stock
1976
0
D
Non-Qualified Stock Option (right to buy)
88.76
2018-06-21
4
X
0
13219
0.0
D
2025-02-11
Common Stock
13219
0
D
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
Transaction is the exercise of a derivative security; see Column 2.
Options exercisable one-third annually over the first three anniversaries of the grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2018.
By: Alejandro Parras, Attorney-In-Fact For: Alison Burcar
2018-06-21